HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3',4'- dichloro- 3- (3,4- dichlorophenylacetyl)- 2,4,6- trihydroxydeoxybenzoin

structure in first source

Also Known As:

DC-DCP-THB cpd

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        3',4'-dichloro-3-(3,4-dichlorophenylacetyl)-2,4,6-trihydroxydeoxybenzoin: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        3',4'-dichloro-3-(3,4-dichlorophenylacetyl)-2,4,6-trihydroxydeoxybenzoin: 1

Experts

1.	Chang, Chih-Shiang: 1 article (11/2008)
2.	Chen, Jung-Tsan: 1 article (11/2008)
3.	Fong, Yi-Chin: 1 article (11/2008)
4.	Hsu, Che-Wei: 1 article (11/2008)
5.	Li, Te-Mao: 1 article (11/2008)
6.	Liu, Ju-Fang: 1 article (11/2008)
7.	Tang, Chih-Hsin: 1 article (11/2008)

Related Diseases

1.	Osteosarcoma (Osteogenic Sarcoma) 11/12/2008 - "In the present study, we investigated the anticancer effect of a new isoflavone derivative, 3',4'-dichloro-3-(3,4-dichlorophenylacetyl)-2,4,6-trihydroxydeoxybenzoin (DDTD) in human osteosarcoma cells. "

Related Drugs and Biologics

1.	Isoflavones